Coexistent of muscle specific tyrosine kinase and acetylcholine receptor antibodies in a myasthenia gravis patient

2010 ◽  
Vol 58 (4) ◽  
pp. 668 ◽  
Author(s):  
Madhuri Behari ◽  
Hamid Suhail ◽  
Subbiah Vivekanandhan ◽  
Sumit Singh
10.1038/85520 ◽  
2001 ◽  
Vol 7 (3) ◽  
pp. 365-368 ◽  
Author(s):  
Werner Hoch ◽  
John McConville ◽  
Sigrun Helms ◽  
John Newsom-Davis ◽  
Arthur Melms ◽  
...  

1988 ◽  
Vol 540 (1 Advances in N) ◽  
pp. 554-556 ◽  
Author(s):  
TAKESHI SATO ◽  
YASUNORI ISHIGAKI ◽  
TADATOSHI KOMIYA ◽  
HIROSHI TSUDA

2021 ◽  
Author(s):  
Vasiliki Zouvelou ◽  
Maria Michail ◽  
Maria Belimezi ◽  
Paraskevi Zisimopoulou

2001 ◽  
Vol 59 (3B) ◽  
pp. 681-685 ◽  
Author(s):  
Maria da Penha A. Morita ◽  
Alberto A. Gabbai ◽  
Acary S.B. Oliveira ◽  
Audrey S. Penn

Myasthenia gravis (MG) in childhood is rare comprising 10 to 20 % of all myasthenic patients. We studied 18 patients with MG whose first symptoms started from 1 to 12 years of age, followed at the Department of Neurology of the UNIFESP-EPM, from January 1983 to August 1997. There were 10 girls and 8 boys (1.2:1). Eleven patients (61%) presented moderate or severe generalized disease and 4 (22%) had at least one myasthenic crisis. EMG with supramaximal repetitive nerve stimulation was diagnostic in 8 (47%) out of 17 patients, and chest CT was normal in 14 patients. Seropositivity to acetylcholine receptor antibodies was found in 81.6% (9 out of 11 tested) and the levels had no relation to clinical severity. Nine out of 16 patients (56%) worsened with pyridostigmine alone and were treated with prednisone. Four out of those nine continued worsening despite steroids and were subjected to thymectomy (all showed thymic lymphoid follicular hyperplasia). Three patients (75%) improved markedly after thymectomy and one (25%) worsened, eventually getting better with intravenous immunoglobulin and oral azathioprine. MG treatment, using all resources available, has to be individualized for each child.


2018 ◽  
Vol 5 (2) ◽  
pp. 261-264 ◽  
Author(s):  
Ellen Strijbos ◽  
Jan J.G.M. Verschuuren ◽  
Jan B.M. Kuks

1980 ◽  
Vol 301 (2) ◽  
pp. 127-128 ◽  
Author(s):  
K. Heininger ◽  
A. Fateh-Moghadam ◽  
K. V. Toyka ◽  
U. A. Besinger ◽  
J. Witthöft

1985 ◽  
Vol 31 (6) ◽  
pp. 835-840 ◽  
Author(s):  
C L Hinman ◽  
C M Kellogg ◽  
R M Ernstoff ◽  
H C Rauch ◽  
R A Hudson

Abstract We used a "sandwich"-type immunoenzymometric assay (IEMA) and a radioimmunoassay (RIA) to measure antibody against the human nicotinic acetylcholine receptor in serum from individuals with myasthenia gravis, with markedly different results for certain specimens, as measured by the two techniques. In some cases, antibody concentrations were high by RIA but low by IEMA; in others, the reverse was found. Such differences persisted through 30 months after thymectomy. An investigation of potential causes of this disparity suggests that high IEMA measurements reflect specific anti-receptor antibody and are not artifactual. The IEMA is recommended as an adjunct to the RIA because some patients with myasthenia gravis who have low concentrations of anti-receptor antibodies as measured by RIA have significantly above-normal concentrations of anti-receptor antibodies as measured by IEMA.


Sign in / Sign up

Export Citation Format

Share Document